State Ledger
Company profile

ARTELO BIOSCIENCES, INC. CIK 1621221

Ticker
ARTL (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Solana Beach, CA 92075
Fiscal year end
2025 (FY)
Market Data
Close
$2.99
Change
-$0.16
Change %
-5.08%
Volume
593

ARTL · trading date Oct 13, 2026 · previous close $3.15 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$12.88M
Total assets
$2.80M
Total liabilities
$4.07M
Stockholders' equity
-$1.27M
Cash & equivalents
$600.0K
Operating income
-$11.40M
Operating cash flow
-$8.52M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-02-24. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
145.4%
Equity / assets
-45.4%
CapEx / revenue
—
Operating cash flow / net income
0.66×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$12.88M $2.80M $4.07M -$1.27M
2024 — -$9.83M $4.70M $1.84M $2.86M
2023 — -$9.29M $13.04M $1.29M $11.75M
2022 — -$10.08M $20.42M $1.02M $19.40M
2021 — -$9.41M $28.25M $1.08M $27.17M
Company Details
SIC code
2834
State of incorporation
NV
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-08-27
Financials filed via
Form 10-K
filed 2026-02-24

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Solana Beach, CA 92075
505 LOMAS SANTA FE, SUITE 160
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:04 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies